Patent · US Active

Dexrabeprazole sodium compound and pharmaceutical composition thereof

US11078184B2 · kind B2 · utility

0Cited by

0References

4Claims

0Family size

Assignees

JIANGSU AOSAIKANG PHARMACEUTICAL CO., LTD. · CN
NANJING HAIRUN PHARMACEUTICAL CO., LTD. · CN

Inventors

Xiangfeng Chen · Xiamen, CN
Hongyu Chen · Beijing, CN
Xiaoxin Li · Nanjing, CN
Xun Pan · Nanjing, CN
Min Sun · Shanghai, CN

Key dates

Filing date	Jun 22, 2018
Grant date	Aug 3, 2021
Priority date	—
Expiry date	Jul 5, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/13
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A dexrabeprazole sodium compound includes crystal forms B and C. The crystal form B has good stability and flowability. The crystal form C is an anhydrous crystal form and has good stability and low hygroscopicity. The crystal forms are suitable for preparing a dexrabeprazole sodium preparation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.